Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Biblos-e Archivo. Repositorio Institucional de la UAM
Publication Artículo científico (JournalArticle)

Associations of dietary intake on biological markers of inflammation in children and adolescents: A systematic review

  • Bujtor, Melissa
  • Turner, Anne I.
  • Torres, Susan J.
  • Esteban Gonzalo, Laura
  • Pariante, Carmine M.
  • Borsini, Alessandra
Background: In children and adolescents, chronic low-grade inflammation has been implicated in the pathogenesis of co- and multi-morbid conditions to mental health disorders. Diet quality is a potential mechanism of action that can exacerbate or ameliorate low-grade inflammation; however, the exact way dietary intake can regulate the immune response in children and adolescents is still to be fully understood. Methods: Studies that measured dietary intake (patterns of diet, indices, food groups, nutrients) and any inflammatory biomarkers in children and adolescents aged 2 to19 years and published until November 2020 were included in this systematic review, and were selected in line with PRISMA guidelines through the following databases: Academic Search Complete, CINAHL, Global Health, Medline COMPLETE andWeb of Science-Core Collection. A total of 53 articles were identified. Results: Results show that adequate adherence to healthful dietary patterns such as the Mediterranean diet, or food groups such as vegetables and fruit, or macro/micro nutrients such as fibre or vitamin C and E, are associated with decreased levels of pro-inflammatory biomarkers, mainly c-reactive protein (CRP), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α), whereas adherence to aWestern dietary pattern, as well as intake of food groups such as added sugars, macro-nutrients such as saturated fatty acids or ultra-processed foods, is associated with higher levels of the same pro-inflammatory biomarkers. Conclusions: This is the first systematic review examining dietary intake and biological markers of inflammation in both children and adolescents. A good quality diet, high in vegetable and fruit intake, wholegrains, fibre and healthy fats ameliorates low-grade inflammation, and therefore represents a promising therapeutic approach, as well as an important element for disease prevention in both children and adolescents., A.B. and C.M.P. are funded by the UK Medical Research Council (grants MR/L014815/1, MR/J002739/1and MR/N029488/1), the European Commission Horizon 2020 (grant SC1-BHC-01- 2019) and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London; they have also received research funding from Johnson and Johnson for research on depression and inflammation, but this paper is independent from this funding. In addition, C.M.P. is funded by the Wellcome Trust strategy award to the Neuroimmunology of Mood Disorders and Alzheimer’s Disease (NIMA) Consortium (104025), which is also funded by Janssen, GlaxoSmithKline, Lundbeck and Pfizer, but, again, this paper is independent from this funding.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis

  • Clària, Joan
  • Marcos Fa, Xavi
  • Giarracco, Emma
  • Cerutti, Andrea, 1965-
  • Moreau, Richard
Background & aims: Patients with acutely decompensated (AD) cirrhosis are immunocompromised and particularly susceptible to infections. This study investigated the immunomodulatory actions of albumin by which this protein may lower the incidence of infections. Methods: Blood immunophenotyping was performed in 11 patients with AD cirrhosis and 10 healthy volunteers (HV). Bulk and single-cell RNA sequencing (scRNA-seq) and flow cytometry were performed in peripheral blood mononuclear cells (PBMCs) from 20 patients with AD cirrhosis and 34 HV exposed to albumin. Albumin's effects on degranulation, phagocytosis, chemotaxis, and swarming of neutrophils from six patients with AD cirrhosis and nine HV were assessed by measuring myeloperoxidase enzymatic activity, the engulfment of fluorescent-labeled Escherichia coli and zymosan, and interactions of neutrophils with Candida albicans at single-cell resolution in microfluidic chambers, respectively. Whole blood RNA sequencing (RNA-seq) analyses were performed in 49 patients admitted for severe AD cirrhosis, of whom 30 received albumin during hospitalization. Results: Compared with HV, patients with AD cirrhosis showed severe lymphopenia and defective neutrophil antimicrobial function. Bulk and scRNA-seq analyses revealed significantly (false discovery rate [FDR] <0.05) increased signatures related to B cells, myeloid cells, and CD4+ T cells in PBMCs incubated with albumin. Changes in the B cell population were confirmed by flow cytometry. Neutrophils exposed to albumin also exhibited augmented chemotactic and degranulation responses, enhanced phagocytosis, and increased pathogen-restrictive swarming. RNA-seq data analysis in patients who had received albumin revealed specific upregulation of signatures related to B cells and neutrophils together with transcriptional changes in CD4+ T cells (FDR <0.05). Conclusions: The finding that albumin promotes the transcriptional reprogramming and expansion of the B cell compartment and improves neutrophil antimicrobial functions indicates mechanisms that may lower the incidence of infections in patients with severe AD cirrhosis receiving albumin therapy. Impact and implications: Patients with acutely decompensated cirrhosis receiving albumin as treatment have a lower incidence of infections. The reason for this protection is currently unknown, but the present study provides data that support the ability of albumin to boost the antimicrobial functions of immune cells in these patients. Moreover, these findings encourage the design of controlled clinical studies specifically aimed at investigating the effects of albumin administration on the immune system., This research was supported by EF CLIF, a private, non-profit organization receiving unrestricted grants from Grifols and Fundació Privada Cellex. EF CLIF is a partner and/or coordinator of several European Union (EU) Horizon 2020 program projects (Nos. 825694 and 847949). This study was also supported by Ministerio de Ciencia e Innovacion/Agencia Estatal Investigación MCIN/AEI, PID2022-138970OB-I00 10.13039/501100011033/FEDER, UE (to JC) and RTI2018-093894-B-I00 (to AC). LJ-G has held an FPU PhD fellowship (FPU19/04886) from the Spanish Ministry of Science, Innovation and Universities. EW was an EF CLIF Research Fellow who received grants from Fundació Privada Cellex and the Fondation Bettencourt-Schueller. IH received a Marie Skłodowska-Curie grant agreement (No. 75451) from the EU’s Horizon 2020 Research and Innovation Program. The funders had no influence on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics

  • Ruffini, Giulio
  • Damiani, Giada
  • Lozano-Soldevilla, Diego
  • Deco, Nikolas
  • Rosas, Fernando E.
  • Kiani, Narsis A.
  • Ponce-Alvarez, Adrián
  • Kringelbach, Morten L.
  • Carhart-Harris, Robin L.
  • Deco, Gustavo
Includes supplementary materials for the online appendix., A topic of growing interest in computational neuroscience is the discovery of fundamental principles underlying global dynamics and the self-organization of the brain. In particular, the notion that the brain operates near criticality has gained considerable support, and recent work has shown that the dynamics of different brain states may be modeled by pairwise maximum entropy Ising models at various distances from a phase transition, i.e., from criticality. Here we aim to characterize two brain states (psychedelics-induced and placebo) as captured by functional magnetic resonance imaging (fMRI), with features derived from the Ising spin model formalism (system temperature, critical point, susceptibility) and from algorithmic complexity. We hypothesized, along the lines of the entropic brain hypothesis, that psychedelics drive brain dynamics into a more disordered state at a higher Ising temperature and increased complexity. We analyze resting state blood-oxygen-level-dependent (BOLD) fMRI data collected in an earlier study from fifteen subjects in a control condition (placebo) and during ingestion of lysergic acid diethylamide (LSD). Working with the automated anatomical labeling (AAL) brain parcellation, we first create “archetype” Ising models representative of the entire dataset (global) and of the data in each condition. Remarkably, we find that such archetypes exhibit a strong correlation with an average structural connectome template obtained from dMRI (r = 0.6). We compare the archetypes from the two conditions and find that the Ising connectivity in the LSD condition is lower than in the placebo one, especially in homotopic links (interhemispheric connectivity), reflecting a significant decrease of homotopic functional connectivity in the LSD condition. The global archetype is then personalized for each individual and condition by adjusting the system temperature. The resulting temperatures are all near but above the critical point of the model in the paramagnetic (disordered) phase. The individualized Ising temperatures are higher in the LSD condition than in the placebo condition (p = 9 × 10−5). Next, we estimate the Lempel-Ziv-Welch (LZW) complexity of the binarized BOLD data and the synthetic data generated with the individualized model using the Metropolis algorithm for each participant and condition. The LZW complexity computed from experimental data reveals a weak statistical relationship with condition (p = 0.04 one-tailed Wilcoxon test) and none with Ising temperature (r(13) = 0.13, p = 0.65), presumably because of the limited length of the BOLD time series. Similarly, we explore complexity using the block decomposition method (BDM), a more advanced method for estimating algorithmic complexity. The BDM complexity of the experimental data displays a significant correlation with Ising temperature (r(13) = 0.56, p = 0.03) and a weak but significant correlation with condition (p = 0.04, one-tailed Wilcoxon test). This study suggests that the effects of LSD increase the complexity of brain dynamics by loosening interhemispheric connectivity—especially homotopic links. In agreement with earlier work using the Ising formalism with BOLD data, we find the brain state in the placebo condition is already above the critical point, with LSD resulting in a shift further away from criticality into a more disordered state., GR, GiD, DL-S, ND have received funding from the European Research Council (ERC Synergy Galvani) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 855109). GR, GD, GiD, DL-S and ND have received funding from European Union’s Horizon 2020 research and innovation programme under grant agreement No 101017716 (Neurotwin). FER is supported by the Ad Astra Chandaria foundation. NAK has received funding from the European Union under the Horizon 2020 programme (MultipleMS grant agreement 733161 and DECISION Grant agreement 847949). AP-A was supported by the Human Brain Project SGA3 (945539) and the Ramón y Cajal fellowship (RYC2020-029117-I). RC-H is supported by the Ralph Metzner Distinguished Professorship endowment. GD has received funding from the Spanish national research project (ref. AEI-PID2019-105772GB-I00/AEI/10.13039/501100011033) funded by the Spanish Ministry of Science, Innovation and Universities (MCIU), State Research Agency (AEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Biblos-e Archivo. Repositorio Institucional de la UAM
Publication Artículo científico (JournalArticle)

Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD, Cirrhosis and Liver Failure

  • Jachs, Mathias
  • Llop Herrera, Elba
  • Calleja Panero, José Luis
Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar, el nombre del grupo de colaboración, si le hubiere, y los autores pertenecientes a la UAM, Background & Aims The NICER (liver and spleen stiffness by vibration-controlled transient elastography, platelet count, and BMI) and the ANTICIPATE±NASH models predict clinically significant portal hypertension (CSPH) in compensated advanced chronic liver disease (cACLD). This study reports follow-up data from the NICER cohort, comparing the prognostic utility of non-invasive tests for CSPH (CSPH-NITs) and hepatic venous pressure gradient (HVPG). Methods Patients with Child-Turcotte-Pugh A cACLD (liver stiffness ≥10 kPa and/or F3/4) from 16 European centres undergoing paired HVPG and CSPH-NIT assessment between 2020-2023 were included and followed until incident hepatic decompensation, hepatocellular carcinoma, death, or last visit. Results Three hundred and fifty-eight patients with cACLD were included (MASLD: 40.7%; MetALD/ALD: 32.1%; viral: 16.2%), with a CSPH prevalence of 62.0%. The cumulative 1-year and 2-year incidences of decompensation were 7.3 (95% CI 5.9–8.7%) and 12.6 (10.3–14.9%). Albumin levels were a key predictor of decompensation (subdistribution hazard ratio [sHR] 0.836; 95% CI 0.779–0.897), alongside HVPG (albumin-adjusted SHR 1.126; 95% CI 1.059–1.198), NICER (albumin-adjusted SHR 1.207; 95% CI 1.043–1.397), or ANTICIPATE±NASH (albumin-adjusted SHR 1.174; 95% CI 1.003–1.374). Models incorporating albumin alongside HVPG or CSPH-NIT achieved high C-indices for decompensation (0.772–0.806). Stratifying patients by a predicted 1-year decompensation-free survival probability of ≥95% or <95% identified approximately 60% of patients as being at negligible 1-year risk (1.4-2.1%), while the remaining patients were at high risk of decompensation (14.3-16.0%). Conclusion In our multicentre study of contemporary European patients with cACLD, non-invasively estimated CSPH risk was as predictive for decompensation as HVPG. Models comprising indicators of portal hypertension and albumin discriminated between patients at negligible decompensation risk and those with a 1-year risk of approximately 15%, i.e. the potential target population for preventive strategies. Impact and implications Non-invasive tests (NITs) facilitate the early diagnosis and management of clinically significant portal hypertension in patients with compensated advanced chronic liver disease (cACLD). In our contemporary cohort of patients with cACLD, mainly steatotic liver disease, recruited at 16 European expert centres, the hepatic venous pressure gradient and NITs were similarly predictive of decompensation within 1 to 2 years of follow-up. Serum albumin levels were identified as the second main predictor of decompensation after hepatic venous pressure gradient or NITs for clinically significant portal hypertension. Novel models were developed that could accurately predict the risk of decompensation, thereby refining point-of-care risk stratification and informing clinical trial design for patients with CTP-A cACLD, The coordination of the study was supported by a research grant from Echosens. However, Echosens was not involved in the design or conduct of the study, analysis of data, or writing of the manuscript. M.J., M.M., T.R. and M.T. receive financial support from “Clinical Research Group MOTION, Medical University of Vienna, Vienna, Austria – a project funded by the Clinical Research Groups Programme of the Ludwig Boltzmann Gesellschaft (Grant Nr: LBG_KFG_22_32) with funds from the Fonds Zukunft Österreich”. P-E.R.’s laboratory receives financial supports from the “Institut National de la Santé et de la Recherche Médicale” (ATIP AVENIR), the “Agence Nationale de la Recherche” (ANR-18-CE14-0006-01, RHU QUID-NASH, ANR-18-IDEX-0001), “Émergence, Ville de Paris”, Fondation ARC and from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847949 (DECISION)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

  • Torres, Sandra
  • Ortiz, Cristina
  • Bachtler, Nadine
  • Gu, Wenyi
  • Grünewald, Leon D.
  • Kraus, Nico
  • Schierwagen, Robert
  • Hieber, Christoph
  • Meier, Caroline
  • Tyc, Olaf
  • Brol, Maximilian Joseph
  • Uschner, Frank Erhard
  • Nijmeijer, Bart
  • Welsch, Christoph
  • Berres, Marie-Luise
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
  • Trautwein, Christian
  • Vogl, Thomas J.
  • Zeuzem, Stefan
  • Trebicka, Jonel
  • Klein, Sabine
anus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with portal hypertension. JAK2 inhibitors, such as pacritinib, are already in advanced clinical development for other indications and might also be effective in liver fibrosis. Here, we investigated the antifibrotic role of the JAK2 inhibitor pacritinib on activated hepatic stellate cells (HSCs) in vitro and in two animal models of liver fibrosis in vivo., Jonel Trebicka is supported by the German Research Foundation project ID 403224013–SFB 1382 (A09); by the German Federal Ministry of Education and Research (BMBF) for the DEEP‐HCC project; by the Hessian Ministry of Higher Education, Research, and the Arts (HMWK) for the ENABLE cluster project; and by Eurostars (Grant ID 12350). The MICROB‐PREDICT (project ID 825694), DECISION (project ID 847949), GALAXY (project ID 668031), LIVERHOPE (project ID 731875), and IHMCSA (project ID 964590) projects have received funding from the European Union's Horizon 2020 research and innovation program. The manuscript reflects only the authors' views, and the European Commission is not responsible for any use that may be made of the information it contains. The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Palmitoylcarnitine impairs immunity in decompensated cirrhosis

  • Wei Zhang, Ingrid
  • Sánchez-Rodríguez, María Belén
  • López-Vicario, Cristina
  • Casulleras, Mireia
  • Duran-Güell, Marta
  • Flores-Costa, Roger
  • Aguilar, Ferran
  • Rothe, Michael
  • Segalés, Paula
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
  • Trebicka, Jonel
  • Arroyo, Vicente
  • Clària, Joan
In patients with cirrhosis, acute decompensation (AD) correlates with a hyperinflammatory state driven by mitochondrial dysfunction, which is a significant factor in the progression toward acute-on-chronic liver failure (ACLF). Elevated circulating levels of acylcarnitine, indicative of mitochondrial dysfunction, are predictors of mortality in ACLF patients. Our hypothesis posits that acylcarnitines not only act as biomarkers, but also actively exert detrimental effects on circulating immune cells., Supported by the Plan Nacional de I+D funded by the Agencia Estatal de Investigación (grants PID2019-105240RB-I00 and PID2022-138970OB-I00 [to JC] and PID2019-111669RB-100 and PID2020-115055RB-I00 [to JCF-C]). JC laboratory is a Consolidated Research Group recognised by the Generalitat de Catalunya (2021 SGR 01323) and receives funds from EF CLIF and European Union’s Horizon 2020 research and innovation programme (MICROB-PREDICT [project ID 825694], DECISION [project ID 847949]). JCF-C receives funds from the center grant P50AA011999 Southern California Research Center for ALPD and Cirrhosis funded by NIAAA/NIH, the Project 201916/31 by Fundació Marató TV3 and the European Horizon´s research and innovation program HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679. JT is supported by the German Research Foundation project ID 403224013 – SFB 1382 (A09), by the German Federal Ministry of Education and Research for the DEEP-HCC project and by the Hessian Ministry of Higher Education, Research, the Arts for the ENABLE and ACLF-I cluster projects and the European Union’s Horizon 2020 research and innovation program for MICROB-PREDICT (project ID 825694), DECISION (project ID 847949), GALAXY (project ID 668031), LIVERHOPE (project ID 731875), and IHMCSA (project ID 964590) projects. IWZ was supported by the Sheila Sherlock Post Graduate Programme of the European Association for the Study of the Liver., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics

  • Ruffini, Giulio
  • Damiani, Giada
  • Lozano-Soldevilla, Diego
  • Deco, Nikolas
  • Rosas, Fernando E.
  • Kiani, Narsis A.
  • Ponce-Alvarez, Adrián
  • Kringelbach, Morten L.
  • Carhart-Harris, Robin L.
  • Deco, Gustavo
Includes supplementary materials for the online appendix., A topic of growing interest in computational neuroscience is the discovery of fundamental principles underlying global dynamics and the self-organization of the brain. In particular, the notion that the brain operates near criticality has gained considerable support, and recent work has shown that the dynamics of different brain states may be modeled by pairwise maximum entropy Ising models at various distances from a phase transition, i.e., from criticality. Here we aim to characterize two brain states (psychedelics-induced and placebo) as captured by functional magnetic resonance imaging (fMRI), with features derived from the Ising spin model formalism (system temperature, critical point, susceptibility) and from algorithmic complexity. We hypothesized, along the lines of the entropic brain hypothesis, that psychedelics drive brain dynamics into a more disordered state at a higher Ising temperature and increased complexity. We analyze resting state blood-oxygen-level-dependent (BOLD) fMRI data collected in an earlier study from fifteen subjects in a control condition (placebo) and during ingestion of lysergic acid diethylamide (LSD). Working with the automated anatomical labeling (AAL) brain parcellation, we first create “archetype” Ising models representative of the entire dataset (global) and of the data in each condition. Remarkably, we find that such archetypes exhibit a strong correlation with an average structural connectome template obtained from dMRI (r = 0.6). We compare the archetypes from the two conditions and find that the Ising connectivity in the LSD condition is lower than in the placebo one, especially in homotopic links (interhemispheric connectivity), reflecting a significant decrease of homotopic functional connectivity in the LSD condition. The global archetype is then personalized for each individual and condition by adjusting the system temperature. The resulting temperatures are all near but above the critical point of the model in the paramagnetic (disordered) phase. The individualized Ising temperatures are higher in the LSD condition than in the placebo condition (p = 9 × 10−5). Next, we estimate the Lempel-Ziv-Welch (LZW) complexity of the binarized BOLD data and the synthetic data generated with the individualized model using the Metropolis algorithm for each participant and condition. The LZW complexity computed from experimental data reveals a weak statistical relationship with condition (p = 0.04 one-tailed Wilcoxon test) and none with Ising temperature (r(13) = 0.13, p = 0.65), presumably because of the limited length of the BOLD time series. Similarly, we explore complexity using the block decomposition method (BDM), a more advanced method for estimating algorithmic complexity. The BDM complexity of the experimental data displays a significant correlation with Ising temperature (r(13) = 0.56, p = 0.03) and a weak but significant correlation with condition (p = 0.04, one-tailed Wilcoxon test). This study suggests that the effects of LSD increase the complexity of brain dynamics by loosening interhemispheric connectivity—especially homotopic links. In agreement with earlier work using the Ising formalism with BOLD data, we find the brain state in the placebo condition is already above the critical point, with LSD resulting in a shift further away from criticality into a more disordered state., GR, GiD, DL-S, ND have received funding from the European Research Council (ERC Synergy Galvani) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 855109). GR, GD, GiD, DL-S and ND have received funding from European Union’s Horizon 2020 research and innovation programme under grant agreement No 101017716 (Neurotwin). FER is supported by the Ad Astra Chandaria foundation. NAK has received funding from the European Union under the Horizon 2020 programme (MultipleMS grant agreement 733161 and DECISION Grant agreement 847949). AP-A was supported by the Human Brain Project SGA3 (945539) and the Ramón y Cajal fellowship (RYC2020-029117-I). RC-H is supported by the Ralph Metzner Distinguished Professorship endowment. GD has received funding from the Spanish national research project (ref. AEI-PID2019-105772GB-I00/AEI/10.13039/501100011033) funded by the Spanish Ministry of Science, Innovation and Universities (MCIU), State Research Agency (AEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis

  • Clària, Joan
  • Marcos Fa, Xavi
  • Giarracco, Emma
  • Cerutti, Andrea, 1965-
  • Moreau, Richard
Background & aims: Patients with acutely decompensated (AD) cirrhosis are immunocompromised and particularly susceptible to infections. This study investigated the immunomodulatory actions of albumin by which this protein may lower the incidence of infections. Methods: Blood immunophenotyping was performed in 11 patients with AD cirrhosis and 10 healthy volunteers (HV). Bulk and single-cell RNA sequencing (scRNA-seq) and flow cytometry were performed in peripheral blood mononuclear cells (PBMCs) from 20 patients with AD cirrhosis and 34 HV exposed to albumin. Albumin's effects on degranulation, phagocytosis, chemotaxis, and swarming of neutrophils from six patients with AD cirrhosis and nine HV were assessed by measuring myeloperoxidase enzymatic activity, the engulfment of fluorescent-labeled Escherichia coli and zymosan, and interactions of neutrophils with Candida albicans at single-cell resolution in microfluidic chambers, respectively. Whole blood RNA sequencing (RNA-seq) analyses were performed in 49 patients admitted for severe AD cirrhosis, of whom 30 received albumin during hospitalization. Results: Compared with HV, patients with AD cirrhosis showed severe lymphopenia and defective neutrophil antimicrobial function. Bulk and scRNA-seq analyses revealed significantly (false discovery rate [FDR] <0.05) increased signatures related to B cells, myeloid cells, and CD4+ T cells in PBMCs incubated with albumin. Changes in the B cell population were confirmed by flow cytometry. Neutrophils exposed to albumin also exhibited augmented chemotactic and degranulation responses, enhanced phagocytosis, and increased pathogen-restrictive swarming. RNA-seq data analysis in patients who had received albumin revealed specific upregulation of signatures related to B cells and neutrophils together with transcriptional changes in CD4+ T cells (FDR <0.05). Conclusions: The finding that albumin promotes the transcriptional reprogramming and expansion of the B cell compartment and improves neutrophil antimicrobial functions indicates mechanisms that may lower the incidence of infections in patients with severe AD cirrhosis receiving albumin therapy. Impact and implications: Patients with acutely decompensated cirrhosis receiving albumin as treatment have a lower incidence of infections. The reason for this protection is currently unknown, but the present study provides data that support the ability of albumin to boost the antimicrobial functions of immune cells in these patients. Moreover, these findings encourage the design of controlled clinical studies specifically aimed at investigating the effects of albumin administration on the immune system., This research was supported by EF CLIF, a private, non-profit organization receiving unrestricted grants from Grifols and Fundació Privada Cellex. EF CLIF is a partner and/or coordinator of several European Union (EU) Horizon 2020 program projects (Nos. 825694 and 847949). This study was also supported by Ministerio de Ciencia e Innovacion/Agencia Estatal Investigación MCIN/AEI, PID2022-138970OB-I00 10.13039/501100011033/FEDER, UE (to JC) and RTI2018-093894-B-I00 (to AC). LJ-G has held an FPU PhD fellowship (FPU19/04886) from the Spanish Ministry of Science, Innovation and Universities. EW was an EF CLIF Research Fellow who received grants from Fundació Privada Cellex and the Fondation Bettencourt-Schueller. IH received a Marie Skłodowska-Curie grant agreement (No. 75451) from the EU’s Horizon 2020 Research and Innovation Program. The funders had no influence on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics

  • Ruffini, Giulio
  • Damiani, Giada
  • Lozano-Soldevilla, Diego
  • Deco, Nikolas
  • Rosas, Fernando E.
  • Kiani, Narsis A.
  • Ponce-Alvarez, Adrián
  • Kringelbach, Morten L.
  • Carhart-Harris, Robin
  • Deco, Gustavo
GR, GiD, DL-S, ND have received funding from the European Research Council (ERC Synergy Galvani) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 855109). GR, GD, GiD, DL-S and ND have received funding from European Union’s Horizon 2020 research and innovation programme under grant agreement No 101017716 (Neurotwin). FER is supported by the Ad Astra Chandaria foundation. NAK has received funding from the European Union under the Horizon 2020 programme (MultipleMS grant agreement 733161 and DECISION Grant agreement 847949). AP-A was supported by the Human Brain Project SGA3 (945539) and the Ramón y Cajal fellowship (RYC2020-029117-I). RC-H is supported by the Ralph Metzner Distinguished Professorship endowment. GD has received funding from the Spanish national research project (ref. AEI-PID2019-105772GB-I00/AEI/10.13039/501100011033) funded by the Spanish Ministry of Science, Innovation and Universities (MCIU), State Research Agency (AEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., A topic of growing interest in computational neuroscience is the discovery of fundamental principles underlying global dynamics and the self-organization of the brain. In particular, the notion that the brain operates near criticality has gained considerable support, and recent work has shown that the dynamics of different brain states may be modeled by pairwise maximum entropy Ising models at various distances from a phase transition, i.e., from criticality. Here we aim to characterize two brain states (psychedelics-induced and placebo) as captured by functional magnetic resonance imaging (fMRI), with features derived from the Ising spin model formalism (system temperature, critical point, susceptibility) and from algorithmic complexity. We hypothesized, along the lines of the entropic brain hypothesis, that psychedelics drive brain dynamics into a more disordered state at a higher Ising temperature and increased complexity. We analyze resting state blood-oxygen-level-dependent (BOLD) fMRI data collected in an earlier study from fifteen subjects in a control condition (placebo) and during ingestion of lysergic acid diethylamide (LSD). Working with the automated anatomical labeling (AAL) brain parcellation, we first create “archetype” Ising models representative of the entire dataset (global) and of the data in each condition. Remarkably, we find that such archetypes exhibit a strong correlation with an average structural connectome template obtained from dMRI (r = 0.6). We compare the archetypes from the two conditions and find that the Ising connectivity in the LSD condition is lower than in the placebo one, especially in homotopic links (interhemispheric connectivity), reflecting a significant decrease of homotopic functional connectivity in the LSD condition. The global archetype is then personalized for each individual and condition by adjusting the system temperature. The resulting temperatures are all near but above the critical point of the model in the paramagnetic (disordered) phase. The individualized Ising temperatures are higher in the LSD condition than in the placebo condition (p = 9 × 10−5). Next, we estimate the Lempel-Ziv-Welch (LZW) complexity of the binarized BOLD data and the synthetic data generated with the individualized model using the Metropolis algorithm for each participant and condition. The LZW complexity computed from experimental data reveals a weak statistical relationship with condition (p = 0.04 one-tailed Wilcoxon test) and none with Ising temperature (r(13) = 0.13, p = 0.65), presumably because of the limited length of the BOLD time series. Similarly, we explore complexity using the block decomposition method (BDM), a more advanced method for estimating algorithmic complexity. The BDM complexity of the experimental data displays a significant correlation with Ising temperature (r(13) = 0.56, p = 0.03) and a weak but significant correlation with condition (p = 0.04, one-tailed Wilcoxon test). This study suggests that the effects of LSD increase the complexity of brain dynamics by loosening interhemispheric connectivity—especially homotopic links. In agreement with earlier work using the Ising formalism with BOLD data, we find the brain state in the placebo condition is already above the critical point, with LSD resulting in a shift further away from criticality into a more disordered state., info:eu-repo/semantics/publishedVersion
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Tesis doctoral (DoctoralThesis)

Unveiling complex diseases through patient stratification and omics analysis: acutely decompensated cirrhosis as a case study

  • Palomino Echeverría, Sara
La tutora de la tesis es Cristina Solano Goñi, Comprender las enfermedades complejas requiere métodos avanzados para entender su heterogeneidad inherente. Dos enfoques claves para desentrañar esta complejidad son (I) la estratificación de pacientes y (II) el análisis de datos ómicos. La combinación de ambos enfoques puede ayudar a identificar subgrupos de pacientes clínicamente relevantes y a elucidar las bases moleculares de la heterogeneidad de la enfermedad, contribuyendo en el avance hacia la medicina de precisión. En esta tesis ilustramos la aplicación práctica de estos enfoques y demostramos su efectividad en el contexto de la cirrosis descompensada aguda (AD), una enfermedad compleja con una variabilidad interindividual significativa. Nuestra investigación tiene como objetivo mejorar el pronóstico de los pacientes mediante estos métodos. En primer lugar, desarrollamos ClustALL, un nuevo enfoque de agrupamiento para una robusta estratificación de pacientes utilizando datos clínicos. ClustALL maneja datos mixtos, valores perdidos y variables correlacionadas, y está disponible como un paquete R Bioconductor. ClustALL demostró ser efectivo para identificar subgrupos de pacientes con AD. Los subgrupos de AD identificados mostraron perfiles clínicos relevantes con valor pronóstico a lo largo del curso de la enfermedad. Estos resultados fueron validados en una cohorte independiente de AD. Es importante destacar la identificación de un subgrupo de pacientes de alto riesgo que mostraba un perfil inflamatorio sistémico agudo marcado, pudiendo estar asociado con una respuesta inmunitaria disfuncional ya descrita en AD. En segundo lugar, dada la asociación de AD con una respuesta inmunitaria disfuncional debido a la inflamación sistémica, estudiamos el sistema inmunológico a nivel molecular para obtener información sobre la fisiopatología de AD y la progresión de la enfermedad. En consecuencia, caracterizamos las poblaciones de células mononucleares de sangre periférica de 16 pacientes con AD y 4 controles sanos, perfilando la expresión génica y los marcadores de superficie proteica a resolución de célula única. Nuestro análisis reveló una subpoblación monocítica CD14+ específica en pacientes con AD que podría estar vinculada a un mayor riesgo de desarrollar insuficiencia hepática aguda sobre crónica (ACLF). Estos monocitos mostraron un perfil de agotamiento, lo que podría llevar a monocitos disfuncionales y contribuir a la progresión de la enfermedad. Definimos y validamos una firma transcripcional de estos monocitos agotados en dos grandes cohortes independientes de AD. En general, esta tesis destaca el potencial de las herramientas bioinformáticas para abordar la heterogeneidad de los pacientes. Hemos desarrollado con éxito una metodología para la estratificación de pacientes utilizando datos clínicos y demostrado su aplicación en el contexto de la cirrosis descompensada aguda. También habilitamos el uso general futuro de este novedoso enfoque creando un paquete R fácil de usar que puede ser utilizado para otras enfermedades complejas. Además, hemos identificado una subpoblación de monocitos que puede estar implicada en la progresión de la cirrosis agudamente descompensada aprovechando el análisis ómico, específicamente el análisis de célula única. Estos esfuerzos destacan el papel crítico de la estratificación de pacientes y los análisis de datos ómicos en el avance de la medicina de precisión con el objetivo final de mejorar el manejo de los pacientes y la prognosis de la enfermedad., Understanding complex diseases requires advanced methods to understand their inherent heterogeneity. Two effective approaches for unravelling this complexity are (I) patient stratification and (II) omics analysis. Combining these approaches can help identify clinically relevant patient subgroups and elucidate the molecular basis of such disease heterogeneity, paving the way for precision medicine. In this thesis, we illustrate the practical application of these approaches and demonstrate their effectiveness in acutely decompensated cirrhosis (AD), a complex disease with significant inter-individual variability. Our research aims to improve patient prognosis through these methods. Firstly, we developed ClustALL, a novel clustering approach for robust patient stratification using clinical data. ClustALL handles mixed data, missing values, and correlated variables, and is available as an R Bioconductor package. The ClustALL method proved effective in identifying AD patient subgroups. The derived AD subgroups showed relevant clinical profiles with demonstrated prognostic value across the course of the disease. Importantly, these results were validated in an independent AD cohort. We identified a high-risk subgroup of patients showing a marked acute systemic inflammatory profile, which can be associated with a dysfunctional immune response already described in AD. Secondly, given the association of AD with a dysfunctional immune response due to systemic inflammation, we studied the immune system at the molecular level to gather insights into the pathophysiology of AD and disease progression. Accordingly, we characterised the peripheral blood mononuclear cell populations of 16 AD patients and 4 healthy controls, profiling gene expression and protein surface markers at single-cell resolution. Our analysis revealed a specific CD14+ monocytic subpopulation in AD patients potentially linked to a higher risk of developing Acute-on-chronic liver failure (ACLF). These monocytes exhibited an exhaustion profile, which could lead to dysfunctional monocytes and contribute to disease progression. We defined and validated a transcriptional signature of these exhausted monocytes in two large independent AD cohorts. Overall, this thesis highlights the potential of bioinformatic tools to address patient heterogeneity. We developed a methodology for patient stratification using clinical data and demonstrated its application in AD. We also enabled the future general use of this novel approach by creating a user-friendly R package that can be used for other complex diseases. Furthermore, we have identified a monocyte subpopulation associated with AD progression by leveraging omics analysis, specifically single-cell analysis. These findings emphasise the importance of patient stratification and omics analyses in advancing precision medicine to improve patient management and outcomes., This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 847949., Programa de Doctorado en Ciencias de la Salud (RD 99/2011), Osasun Zientzietako Doktoretza Programa (ED 99/2011)